有报告利福平用于治疗细菌性呼吸道感染,其治愈率可达80%左右。鉴于慢性肺心病呼吸道感染较顽固,我们应用国产利福平对37例肺心病呼吸道感染住院患者进行治疗。现将疗效报道如下。观察对象和方法一、一般资料:37例患者的诊断均符合1977年全国肺心病专业会议修订的关于《慢性肺原性心脏病诊断标准》。其中男18例,女19例。年龄最小31岁,最大 There are reports of rifampicin for the treatment of bacterial respiratory tract infection, the cure rate of up to 80%. In view of more chronic pulmonary heart disease respiratory tract infection more stubborn, we use domestic rifampicin 37 cases of pulmonary heart disease respiratory patients hospitalized for treatment. The curative effect is reported below. Observations and methods First, the general information: The diagnosis of 37 patients are in line with the National Conference of pulmonary heart disease in 1977 as amended on the “diagnostic criteria for chronic pulmonary heart disease.” There were 18 males and 19 females. The youngest 31 years old, the largest